Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06738199 · ClinicalTrials.gov registry record · NA
Glycoprotein Matrix-Bound Iron Improves Iron Absorption
A NA study of Evaluation of Bioavailability of Supplemental Forms of Iron, sponsored by University of Mary Hardin-Baylor.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT06738199 is a NA study of Evaluation of Bioavailability of Supplemental Forms of Iron that has completed, run by University of Mary Hardin-Baylor. The registered enrollment target is 17 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06738199, a NA study of Evaluation of Bioavailability of Supplemental Forms of Iron, has completed, sponsored by University of Mary Hardin-Baylor.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
A double-blind, randomized crossover study was conducted that evaluated absorption kinetics of 3 forms of dietary supplement iron by measuring iron levels in the blood after acute ingestion.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT dietary iron supplementation
Study Locations (1)
Texas
- Human Performance Lab - Belton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2024-02-01 |
| Est. Completion | 2024-04-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06738199
The ClinicalTrials.gov registry entry for NCT06738199 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Mary Hardin-Baylor, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Evaluation of Bioavailability of Supplemental Forms of Iron appearing as the primary indexed condition, and to 1 intervention - of which dietary iron supplementation is the first listed.
NCT06738199 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06738199 about?
NCT06738199 is a clinical study titled "Glycoprotein Matrix-Bound Iron Improves Iron Absorption". A double-blind, randomized crossover study was conducted that evaluated absorption kinetics of 3 forms of dietary supplement iron by measuring iron levels in the blood after acute ingestion.
What is the current status of trial NCT06738199?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2024-02-01. Estimated completion is 2024-04-22.
What conditions does trial NCT06738199 study?
This clinical trial studies the following conditions: Evaluation of Bioavailability of Supplemental Forms of Iron.
What interventions are being tested in trial NCT06738199?
The interventions under investigation include: dietary iron supplementation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06738199?
This trial is sponsored by University of Mary Hardin-Baylor, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06738199 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.